Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction
Audrey H. Wu,Keith D. Aaronson,Steven F. Bolling,Francis D. Pagani,Kathy Welch,Todd M. Koelling +5 more
Reads0
Chats0
TLDR
There is no clearly demonstrable mortality benefit conferred by MVA for significant MR with severe LV dysfunction, and a prospective randomized control trial is warranted for further study of mortality with MVA in this population.About:
This article is published in Journal of the American College of Cardiology.The article was published on 2005-02-01 and is currently open access. It has received 637 citations till now. The article focuses on the topics: Mitral valve annuloplasty & Mitral regurgitation.read more
Citations
More filters
Journal ArticleDOI
Evaluation of Valtech’s transcatheter mitral valve repair device
TL;DR: Cardioband is a novel technology designed for transcatheter repair of the mitral valve in the treatment of functional MR and the adjustability features under the beating heart and guided by echocardiography allow to provide a tailored therapy to each particular mitral valves and regurgitation condition.
Journal ArticleDOI
The unfinished saga of invasive procedures for secondary mitral regurgitation
Daniel Grinberg,William Uhlrich,Sophie Thivolet,Rémi Buzzi,Gilles Rioufol,Jean-François Obadia,Matteo Pozzi +6 more
TL;DR: The saga of the surgical and percutaneous treatments for secondary MR throughout the previous decades is described to describe the benefits and risks of these procedures.
Journal ArticleDOI
Papillary muscle sling placement for functional mitral regurgitation during minimally invasive valve surgery.
TL;DR: The patient underwent minimally invasive mitral valve repair with placement of a papillary muscle sling, which improved her symptoms and was in heart failure class IV, with dyspnea on minimal exertion.
Journal ArticleDOI
Long-term influence of mild or moderate ischemic mitral regurgitation after off-pump coronary artery bypass surgery.
Jong-Myeon Hong,Raymond Cartier,Michel Pellerin,Philippe Demers,Denis Bouchard,Pierre Couture +5 more
TL;DR: OPCAB patients with preoperative mild or moderate IMR had a higher prevalence of preoperative risk factors than those without IMR but, over the long term, were found to be at risk for recurrent cardiac events.
Journal ArticleDOI
Therapie der Mitralklappeninsuffizienz
Lenard Conradi,Hendrik Treede,Stephan Baldus,Moritz Seiffert,Stefan Blankenberg,Hermann Reichenspurner +5 more
TL;DR: In der Therapie der Mitralklappeninsuffizienz (MI) ist dem prothetischen Klappenersatz hinsichtlich der perioperativen Komplikationsraten und der Langzeitergebnisse deutlich uberlegen.
References
More filters
Journal ArticleDOI
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more
TL;DR: Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Journal ArticleDOI
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Arthur J. Moss,Wojciech Zareba,W. Jackson Hall,Helmut U. Klein,David J. Wilber,David S. Cannom,James P. Daubert,Steven L. Higgins,Mary W. Brown,Mark L. Andrews +9 more
TL;DR: In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.
Journal ArticleDOI
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
Michael R. Bristow,Leslie A. Saxon,John P. Boehmer,Steven K. Krueger,David A. Kass,Teresa De Marco,Peter E. Carson,Lorenzo DiCarlo,David L. DeMets,Bill G. White,Dale W DeVries,Arthur M. Feldman +11 more
TL;DR: In this paper, the authors tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays.
Journal ArticleDOI
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more